282 related articles for article (PubMed ID: 15537486)
1. Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease.
Cavendish JJ; Safani M
Curr Med Res Opin; 2004 Nov; 20(11):1851-5. PubMed ID: 15537486
[TBL] [Abstract][Full Text] [Related]
2. Management of peripheral arterial disease.
Aronow WS
Cardiol Rev; 2005; 13(2):61-8. PubMed ID: 15705252
[TBL] [Abstract][Full Text] [Related]
3. Peripheral arterial disease: a review of disease awareness and management.
Watson K; Watson BD; Pater KS
Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
[TBL] [Abstract][Full Text] [Related]
4. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
5. [Role of antiaggregants in the treatment of arterial diseases of the lower limbs].
Boissel JP
Arch Mal Coeur Vaiss; 1991 Nov; 84(11 Suppl):1721-4. PubMed ID: 1837446
[TBL] [Abstract][Full Text] [Related]
6. Peripheral arterial disease. A systemic disease extending beyond the affected extremity.
Federman DG; Bravata DM; Kirsner RS
Geriatrics; 2004 Apr; 59(4):26, 29-30, 32 passim. PubMed ID: 15086071
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
[TBL] [Abstract][Full Text] [Related]
8. Consensus on anti-platelet therapy in peripheral arterial disease: saving lives and limbs.
Donnelly R; Collinson DJ
Platelets; 2003; 14(7-8):403-6. PubMed ID: 14713508
[No Abstract] [Full Text] [Related]
9. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
10. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
Violi F; Balsano F
Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
[TBL] [Abstract][Full Text] [Related]
11. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
Ferreira AC; Macedo FY
Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
[TBL] [Abstract][Full Text] [Related]
13. Peripheral arterial disease in women.
Aronow WS
Maturitas; 2009 Dec; 64(4):204-11. PubMed ID: 19853389
[TBL] [Abstract][Full Text] [Related]
14. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.
Bhatt DL; Flather MD; Hacke W; Berger PB; Black HR; Boden WE; Cacoub P; Cohen EA; Creager MA; Easton JD; Hamm CW; Hankey GJ; Johnston SC; Mak KH; Mas JL; Montalescot G; Pearson TA; Steg PG; Steinhubl SR; Weber MA; Fabry-Ribaudo L; Hu T; Topol EJ; Fox KA;
J Am Coll Cardiol; 2007 May; 49(19):1982-8. PubMed ID: 17498584
[TBL] [Abstract][Full Text] [Related]
15. New antiplatelet agents: ticlopidine and clopidogrel. Antiplatelet therapy but at what cost?
Black C; Paterson KR
Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):277-303. PubMed ID: 11770173
[No Abstract] [Full Text] [Related]
16. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
17. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
18. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
Sigvant B; Wiberg-Hedman K; Bergqvist D; Rolandsson O; Wahlberg E
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):39-46. PubMed ID: 19237996
[TBL] [Abstract][Full Text] [Related]
19. Risk reduction with clopidogrel in the management of peripheral arterial disease.
Nayak KR; Cavendish JJ
Vasc Health Risk Manag; 2007; 3(3):289-97. PubMed ID: 17703636
[TBL] [Abstract][Full Text] [Related]
20. Peripheral arterial disease: identification and implications.
Mohler ER
Arch Intern Med; 2003 Oct; 163(19):2306-14. PubMed ID: 14581250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
